Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial. [electronic resource]
Producer: 20151109Description: 588 p. digitalISSN:- 1466-609X
- Aged
- Aged, 80 and over
- Anticoagulants -- adverse effects
- Antithrombins -- therapeutic use
- Arginine -- analogs & derivatives
- Critical Illness
- Female
- Hemorrhage -- drug therapy
- Heparin -- adverse effects
- Hirudins
- Humans
- Male
- Middle Aged
- Partial Thromboplastin Time
- Pipecolic Acids -- therapeutic use
- Recombinant Proteins -- therapeutic use
- Renal Insufficiency -- therapy
- Renal Replacement Therapy
- Sulfonamides
- Surgical Procedures, Operative
- Thrombocytopenia -- chemically induced
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.